Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.28 - $1.9 $1,728 - $2,565
-1,350 Reduced 6.34%
19,936 $26,000
Q1 2024

May 20, 2024

BUY
$1.35 - $2.27 $10,265 - $17,261
7,604 Added 55.58%
21,286 $34,000
Q4 2023

Feb 26, 2024

BUY
$1.27 - $2.06 $17,376 - $28,184
13,682 New
13,682 $24,000
Q2 2023

Jul 27, 2023

BUY
$1.14 - $1.63 $17,015 - $24,329
14,926 New
14,926 $24,000
Q2 2022

Aug 09, 2022

BUY
$3.02 - $4.56 $32,259 - $48,709
10,682 New
10,682 $43,000
Q4 2019

Feb 04, 2020

SELL
$6.23 - $7.98 $96,745 - $123,921
-15,529 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$5.62 - $7.86 $87,272 - $122,057
15,529 New
15,529 $106,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $49.9M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.